Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis

Journal of Immunology

Volumn 164, Issue 11, 2000, Pages 5922-5927

  Lu, Jing ^a   Kasama, Tsuyoshi ^a   Kobayashi, Kazuo ^b   Yoda, Yoshiyuki ^a   Shiozawa, Fumitaka ^a   Hanyuda, Michio ^a   Negishi, Masao ^a   Ide, Hirotsugu ^a   Adachi, Mitsuru ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; NEUTRALIZING ANTIBODY; VASCULOTROPIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; VASCULAR ENDOTHELIUM;

EID: 0034114929     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.11.5922     Document Type: Article

References (51)

1. Stuart, J. M., A. S. Townes, and A. H. Kang. 1984. Collagen autoimmune arthritis. Annu. Rev. Immunol. 2:199.
2. Holmdahl, R., M. Andersson, T. J. Goldschmidt, K. Gustafsson, L. Jansson, and J. A. Mo. 1990. Type II collagen autoimmunity in animals and provocations leadirg to arthritis. Immunol. Rev. 118:193.
3. Harris, E. D., Jr. 1990. Rheumatoid arthritis: pathophysiology and implications for therapy. N. Engl. J. Med. 322:1277.
4. Folkman, J., and M. Klagsbrum. 1987. Angiogenic factors. Science 235:442.
5. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:27.
6. Leung, D. W., G. Cachianes, W. J. Kuang, D. V. Goeddel, and N. Ferrara. 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1106.
7. Keck, P. J., S. D. Hauser, G. Krivi, K. Sanzo, T. Warren, J. Feder, and D. T. Connoly. 1989. Vascular permeability factor and endothelial cell mitogen related to PDGF. Science 246:1309.
8. Ferrara, N., K. Houck, L. Jakeman, and D. W. Leung. 1992. Molecular and biological properties of vascular endothelial growth factor family of proteins. Endocr. Rev. 13:18.
9. Fava, R. A., N. J. Olsen, G. Spencer-Green, K.-T. Yeo, T.-K. Yeo, B. Berse, R. W. Jackman, D. R. Senger, H. F. Dvorak, and L. F. Brown. 1994. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J. Exp. Med. 180:341.
10. Koch, A. E., L. A. Harlow, G. K. Haines, E. P. Amenlo, E. N. Unemori, W. L. Wong, R. M. Pope, and N. Ferrara. 1994. Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J. Immunol. 152:4149.
11. Dvorak, H. F., L. F. Brown, M. Detmar, and A. M. Dvorak. 1995. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146:1029.
12. Tilton, R. G., T. Kawamura, K. C. Chang, Y. Ido, R. J. Bjercke, C. C. Stephan, T. A. Brock, and J. R. Williamson. 1997. Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. J. Clin. Invest. 99:2192.
13. Evanoff, H. L., M. D. Burdick, S. A. Moore, S. L. Kunkel, and R. M. Strieter. 1992. A sensitive ELISA for the detection of human monocyte chemoattractant prolein-1 (MCP-1). Immunol. Invest. 21:39.
14. Trentham, D. E., A. S. Townes, and K. A. Kang. 1977. Autoimmunity to type II collagen: an experimental model of arthritis. J. Exp. Med. 146:857.
15. Stuart, J. M., A. S. Townes, and A. H. Kang. 1982. Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J. Clin. Invest. 69:67.1
16. Kasama, T., R. M. Strieter, N. W. Lukacs, P. M. Lincoln, M. D. Burdick, and S. L. Kunkel. 1995. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J. Clin. Invest. 95: 2868.
17. Kasama, T., J. Yamazaki, Y. Hatano, K. Kobayashi, M. Negishi, H. Ide, and M. Adachi. 1999. Biphasic regulation by interleukin 12 of the development of murine type II collagen-induced arthritis: possible involvement of endogenous interleukin 10 and tumor necrosis factor α. Arthritis Rheum. 42:100.
18. Wooley, P. H., J. D. Whalen, and J. M. Chapdelaine. 1989. Collagen-induced arthritis in mice. VI. Synovial cells from collagen arthritic mice activate autologous lymphocytes in vitro. Cell. Immunol. 124:227
19. Jonsson, R., A. Tarkowski, and L. Klareskog. 1986. A demineralization procedure for immunohistopathological use EDTA treatment preserves lymphoid cell surface antigens. J. Immunol. Methods 88:109.
20. Claffey, K. P., W. O. Wilkison, and B. M. Spiegelman. 1992. Vascular endothelial growth factor: regulation by cell differentiation and activated second messenger pathways. J. Biol. Chem. 267:16317.
21. Finnerty, H., K. Kelleher, G. E. Morris, K. Bean, D. M. Merberg, R. Kriz, J. C. Morris, H. Sookdeo, K. J. Turner, and C. R. Wood. 1993. Molecular cloning of murine FLT and FLT4. Oncogene 8:2293.
22. Quinn, T. P., K. G. Peters, C. de Vries, N. Ferrara, and L. T. Williams. 1993. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl. Acad. Sci. USA 90:7533.
23. Ginsburg, D., R. I. Handin, D. T. Bonthron, T. A. Donlon, G. A. P. Bruns, S. A. Latt, and S. H. Orkin. 1985. Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. Science 228:1401.
24. Sugihara, T., S. C. Kaul, Y. Mitsui, and R. Wadhwa. 1994. Enhanced expression of multiple forms of VEGF is associated with spontaneous immortalization of murine fibroblasts. Biochim. Biophys. Acta 1224:365.
25. Mantovani, A., F. Bussolino, and E. Dejana. 1992. Cytokine regulation of endothelial cell function. FASEB J. 6:2591.
26. Koch, A. E., P. J. Polverini, S. L. Kunkel, L. A. Harlow, L. A. DiPietro, V. M. Elner, S. G. Elner, and R. M. Strieter. 1992. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798.
27. Yoshida, S., M. Ono, T. Shone, H. Izumi, T. Ishibashi, H. Suzuki, and M. Kuwano. 1997. Involvement of interleukin-8. vascular endothelial growth factor, and basic fihroblast growth factor in tumor necrosis factor α-dependent angiogenesis. Mol. Cell. Biol. 17:4015.
28. Jackson, J. R., J. A. L. Minton, M. L. Ho, N. Wei, and J. D. Winkler. 1997. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1β. J. Rheumatol. 24:1253.
29. McLaren, J., A. Prentice, D. S. Charnock-Jones, S. A. Millican, K. H. Müller, A. M. Sharkey, and S. K. Smith. 1996. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J. Clin. Invest. 98:482.
30. Xiong, M., G. Elson, D. Legarda, and S. J. Leibovich. 1998. Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am. J. Pathol. 153:587.
31. Maniscalco, W. M., R. H. Watkins, J. N. Finkelstein, and M. H. Campbell. 1995. Vascular endothelial growth factor mRNA increases in alveolar epithelial cells during recovery from oxygen injury. Am. J. Respir. Cell Mol. Biol. 13:377.
32. Brogi, E., T. Wu, A. Namiki, and J. M. Isner. 1994. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90:649.
33. Taichman, N. S., S. Young, A. T. Cruchley, P. Taylor, and E. Paleolog. 1997. Human neutrophils secrete vascular endothelial growth factor. J. Leukocyte Biol. 62:397.
34. Gerber, H.-P., T. H. Vu, A. M. Ryan, J. Kowalski, Z. Werb, and N. Ferrara. 1999. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5:623.
35. Finkenzeller, G., D. Marme, H. A. Weich, and H. Hug. 1992. Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C. Cancer Res. 52:4821.
36. Pertovaar, L., A. Kaipainen, T. Mustonen, A. Orpana, N. Ferrara, O. Saksela, and K. Alitalo. 1994. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J. Biol. Chem. 269:6271.
37. 2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes. J. Biol. Chem. 271:21793.
38. Tuder, R. M., B. E. Flook, and N. F. Voelkel. 1995. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia-modulation of gene expression by nitric oxide. J. Clin. Invest. 95:1798.
39. Dembinskakiec, A., J. Dulak, L. Partyka, I. Huk, and T. Mailnski. 1997. VEGF-nitric oxide reciprocal regulation. Nat. Med. 3:1177.
40. Shweiki, D., A. Itin, D. Soffer, and E. Keshet. 1992. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843.
41. Levick, J. R. 1990. Hypoxia and acidosis in chronic inflammatory arthritis; relation to vascular supply and dynamic effusion pressure. J. Rheumatol. 17:579.
42. Thorbecke, G. J., R. Shah, C. H. Leu, A. P. Kuravilla, A. M. Hardison, and M. A. Palladino. 1992. Involvement of endogenous tumor necrosis factor α and transforming growth factor β during induction of collagen type II arthritis in mice. Proc. Natl. Acad. Sci. USA 89:7375.
43. Horn, J. T., H. Cole, T. Estridge, and V. L. Gliszczynski. 1992. Interleukin-1 enhances the development of type II collagen-induced arthritis only in susceptible and not in resistant mice. Clin. Immunol. Immunopathol. 62:56.
44. van den Berg, W. B., L. A. Joosten, M. Helsen, and F. A. van de Loo. 1994. Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin. Exp. Immunol. 95:237.
45. Brown, L. F., B. Berse, K. Tognazzi, E. J. Manseau, L. van De Water, D. R. Senger, H. F. Dvorak, and S. Rosen. 1992. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int. 42:1457.
46. Neufeld, G., T. Cohen, S. Gengrinovitch, and Z. Pollorak. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13:9.
47. Barleon, B., S. Sozzani, D. Zhou, H. A. Weich, A. Mantovani, and D. Marmé. 1996. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via VEGF receptor flt-1. Blood 87:3336.
48. Hewett, P. W., and J. C. Murray. 1996. Coexpression of flt-1, flt-4 and KDR in freshly isolated and cultured human endothelial cells. Biochem. Biophvs. Res. Commun. 221:697.
49. Gabrilovich, D. I., H. L. Chen, K. R. Girgis, H. T. Cunningham, G. M. Meny, S. Nadaf, D. Kavanaugh, and D. P. Carbone. 1996. Production of vascular endothelial growth factor by human tumors inhibits the functional maturalion of dendritic cells. Nal. Med. 2:1096.
50. Clauss, M., M. Gerlach, H. Gerlach, J. Brett, F. Wang, P. C. Familletti, Y.-C. E. Pan, J. V. Olander, D. T. Connolly, and D. Stern. 1990. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promoles monocyle migration. J. Exp. Med. 172:1535.
51. + T lymphocytes and class II antigen-expressing cells in joints of DBA/1 mice immunized with type II collagen. Lab. Invest. 58:53.